Dallas, TX -- (ReleaseWire) -- 04/24/2014 -- The “Proteomics Market (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, Protein Fractionation, X-ray Crystallography, Immunoassay) - Instruments, Reagents and Services - Trends and Global Forecasts to 2017”, analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.
Browse 211 market data tables, 6 figures spread through 504 pages and in-depth TOC on “Proteomics Market”.
Early buyers will receive 10% customization on this report.
The global proteomics market will be worth an estimated $8.8 billion by the year 2012; North America is the largest market for proteomics, with the U.S. taking the lion’s share, followed by Europe, and Asia. However, North America and Europe are likely to grow at lower CAGRs compared to the Asian market, primarily due to the impact of the economic slowdown in these regions and probable delay in purchase of instruments by companies. The Asian market, especially India and China, is expected to witness a boost in demand for proteomics products and is poised to register maximum growth over the next five years, owing to economic development.
The proteomics market is divided into three major segments, namely, instrumentation technology, reagents, and services. Increasing innovations and developments in the field of proteomics instrumentation, availability of funds from various organizations, and increasing research and development expenditure is driving the growth of the instrumentation and reagents market. The services market is expected to witness significant growth with the emergence of proteomics-specific analytical laboratories and an increasing use of bioinformatics tools in proteomics. However, the economic slowdown, and lower adoption rates due to expensive tools and instruments will restrict the growth of this market to a certain extent.
The key players in the market are Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies (U.S.), Life Technologies (U.S.), Sigma-Aldrich (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), Roche (Switzerland), Bio-Rad (U.S.) and Luminex (U.S.)
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets